Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.
LPI (LP Information)' newest research report, the "Point-of-Care Testing (POCT) Industry Forecast" looks at past sales and reviews total world Point-of-Care Testing (POCT) sales in 2022, providing a comprehensive analysis by region and market sector of projected Point-of-Care Testing (POCT) sales for 2023 through 2029. With Point-of-Care Testing (POCT) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Point-of-Care Testing (POCT) industry.
This Insight Report provides a comprehensive analysis of the global Point-of-Care Testing (POCT) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Point-of-Care Testing (POCT) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Point-of-Care Testing (POCT) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Point-of-Care Testing (POCT) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Point-of-Care Testing (POCT).
The global Point-of-Care Testing (POCT) market size is projected to grow from US$ 25110 million in 2022 to US$ 48170 million in 2029; it is expected to grow at a CAGR of 48170 from 2023 to 2029.
Global Point-of-Care Testing (POCT) main players are Roche, Abbott, Johnson & Johnson, etc. Global top three manufacturers hold a share over 45%. North America is the largest market, with a share nearly 40%.
This report presents a comprehensive overview, market shares, and growth opportunities of Point-of-Care Testing (POCT) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Blood Glucose Testing
- Infectious Diseases Testing
- Cardiac Markers Testing
- Coagulation Testing
- Pregnancy and Fertility Testing
- Blood Gas/Electrolytes Testing
- Urinalysis Testing
Segmentation by application
- Clinics
- Hospitals
- Laboratory
- Others
This report also splits the market by region:
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- Roche
- Abbott
- Johnson & Johnson
- Siemens Healthcare
- Danaher
- Ascensia
- Bio-Rad Laboratories
- BioMerieux
- ARKRAY
- Nova Biomedical
- Trividia Health
- Quidel
- Accriva
- OraSure Technologies
- Helena Laboratories
- A. Menarini Diagnostics
- Abaxis (Zoetis)
- Ortho Clinical Diagnostics
- Phamatech
- Chembio Diagnostics
- Trinity Biotech
- ELITech Group
- Response Biomedical
- Princeton BioMeditech
- Alfa Wassermann
Key Questions Addressed in this Report
What is the 10-year outlook for the global Point-of-Care Testing (POCT) market?
What factors are driving Point-of-Care Testing (POCT) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Point-of-Care Testing (POCT) market opportunities vary by end market size?
How does Point-of-Care Testing (POCT) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Global Point-of-Care Testing (POCT) Market Growth 2023-2029
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Point-of-Care Testing (POCT) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Point-of-Care Testing (POCT) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Point-of-Care Testing (POCT) by Country/Region, 2018, 2022 & 2029
2.2 Point-of-Care Testing (POCT) Segment by Type
2.2.1 Blood Glucose Testing
2.2.2 Infectious Diseases Testing
2.2.3 Cardiac Markers Testing
2.2.4 Coagulation Testing
2.2.5 Pregnancy and Fertility Testing
2.2.6 Blood Gas/Electrolytes Testing
2.2.7 Urinalysis Testing
2.3 Point-of-Care Testing (POCT) Sales by Type
2.3.1 Global Point-of-Care Testing (POCT) Sales Market Share by Type (2018-2023)
2.3.2 Global Point-of-Care Testing (POCT) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Point-of-Care Testing (POCT) Sale Price by Type (2018-2023)
2.4 Point-of-Care Testing (POCT) Segment by Application
2.4.1 Clinics
2.4.2 Hospitals
2.4.3 Laboratory
2.4.4 Others
2.5 Point-of-Care Testing (POCT) Sales by Application
2.5.1 Global Point-of-Care Testing (POCT) Sale Market Share by Application (2018-2023)
2.5.2 Global Point-of-Care Testing (POCT) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Point-of-Care Testing (POCT) Sale Price by Application (2018-2023)
3 Global Point-of-Care Testing (POCT) by Company
3.1 Global Point-of-Care Testing (POCT) Breakdown Data by Company
3.1.1 Global Point-of-Care Testing (POCT) Annual Sales by Company (2018-2023)
3.1.2 Global Point-of-Care Testing (POCT) Sales Market Share by Company (2018-2023)
3.2 Global Point-of-Care Testing (POCT) Annual Revenue by Company (2018-2023)
3.2.1 Global Point-of-Care Testing (POCT) Revenue by Company (2018-2023)
3.2.2 Global Point-of-Care Testing (POCT) Revenue Market Share by Company (2018-2023)
3.3 Global Point-of-Care Testing (POCT) Sale Price by Company
3.4 Key Manufacturers Point-of-Care Testing (POCT) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Point-of-Care Testing (POCT) Product Location Distribution
3.4.2 Players Point-of-Care Testing (POCT) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Point-of-Care Testing (POCT) by Geographic Region
4.1 World Historic Point-of-Care Testing (POCT) Market Size by Geographic Region (2018-2023)
4.1.1 Global Point-of-Care Testing (POCT) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Point-of-Care Testing (POCT) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Point-of-Care Testing (POCT) Market Size by Country/Region (2018-2023)
4.2.1 Global Point-of-Care Testing (POCT) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Point-of-Care Testing (POCT) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Point-of-Care Testing (POCT) Sales Growth
4.4 APAC Point-of-Care Testing (POCT) Sales Growth
4.5 Europe Point-of-Care Testing (POCT) Sales Growth
4.6 Middle East & Africa Point-of-Care Testing (POCT) Sales Growth
5 Americas
5.1 Americas Point-of-Care Testing (POCT) Sales by Country
5.1.1 Americas Point-of-Care Testing (POCT) Sales by Country (2018-2023)
5.1.2 Americas Point-of-Care Testing (POCT) Revenue by Country (2018-2023)
5.2 Americas Point-of-Care Testing (POCT) Sales by Type
5.3 Americas Point-of-Care Testing (POCT) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Point-of-Care Testing (POCT) Sales by Region
6.1.1 APAC Point-of-Care Testing (POCT) Sales by Region (2018-2023)
6.1.2 APAC Point-of-Care Testing (POCT) Revenue by Region (2018-2023)
6.2 APAC Point-of-Care Testing (POCT) Sales by Type
6.3 APAC Point-of-Care Testing (POCT) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Point-of-Care Testing (POCT) by Country
7.1.1 Europe Point-of-Care Testing (POCT) Sales by Country (2018-2023)
7.1.2 Europe Point-of-Care Testing (POCT) Revenue by Country (2018-2023)
7.2 Europe Point-of-Care Testing (POCT) Sales by Type
7.3 Europe Point-of-Care Testing (POCT) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Point-of-Care Testing (POCT) by Country
8.1.1 Middle East & Africa Point-of-Care Testing (POCT) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Point-of-Care Testing (POCT) Revenue by Country (2018-2023)
8.2 Middle East & Africa Point-of-Care Testing (POCT) Sales by Type
8.3 Middle East & Africa Point-of-Care Testing (POCT) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Point-of-Care Testing (POCT)
10.3 Manufacturing Process Analysis of Point-of-Care Testing (POCT)
10.4 Industry Chain Structure of Point-of-Care Testing (POCT)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Point-of-Care Testing (POCT) Distributors
11.3 Point-of-Care Testing (POCT) Customer
12 World Forecast Review for Point-of-Care Testing (POCT) by Geographic Region
12.1 Global Point-of-Care Testing (POCT) Market Size Forecast by Region
12.1.1 Global Point-of-Care Testing (POCT) Forecast by Region (2024-2029)
12.1.2 Global Point-of-Care Testing (POCT) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Point-of-Care Testing (POCT) Forecast by Type
12.7 Global Point-of-Care Testing (POCT) Forecast by Application
13 Key Players Analysis
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Point-of-Care Testing (POCT) Product Portfolios and Specifications
13.1.3 Roche Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Abbott
13.2.1 Abbott Company Information
13.2.2 Abbott Point-of-Care Testing (POCT) Product Portfolios and Specifications
13.2.3 Abbott Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Abbott Main Business Overview
13.2.5 Abbott Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Point-of-Care Testing (POCT) Product Portfolios and Specifications
13.3.3 Johnson & Johnson Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Siemens Healthcare
13.4.1 Siemens Healthcare Company Information
13.4.2 Siemens Healthcare Point-of-Care Testing (POCT) Product Portfolios and Specifications
13.4.3 Siemens Healthcare Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Siemens Healthcare Main Business Overview
13.4.5 Siemens Healthcare Latest Developments
13.5 Danaher
13.5.1 Danaher Company Information
13.5.2 Danaher Point-of-Care Testing (POCT) Product Portfolios and Specifications
13.5.3 Danaher Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Danaher Main Business Overview
13.5.5 Danaher Latest Developments
13.6 Ascensia
13.6.1 Ascensia Company Information
13.6.2 Ascensia Point-of-Care Testing (POCT) Product Portfolios and Specifications
13.6.3 Ascensia Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Ascensia Main Business Overview
13.6.5 Ascensia Latest Developments
13.7 Bio-Rad Laboratories
13.7.1 Bio-Rad Laboratories Company Information
13.7.2 Bio-Rad Laboratories Point-of-Care Testing (POCT) Product Portfolios and Specifications
13.7.3 Bio-Rad Laboratories Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Bio-Rad Laboratories Main Business Overview
13.7.5 Bio-Rad Laboratories Latest Developments
13.8 BioMerieux
13.8.1 BioMerieux Company Information
13.8.2 BioMerieux Point-of-Care Testing (POCT) Product Portfolios and Specifications
13.8.3 BioMerieux Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 BioMerieux Main Business Overview
13.8.5 BioMerieux Latest Developments
13.9 ARKRAY
13.9.1 ARKRAY Company Information
13.9.2 ARKRAY Point-of-Care Testing (POCT) Product Portfolios and Specifications
13.9.3 ARKRAY Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 ARKRAY Main Business Overview
13.9.5 ARKRAY Latest Developments
13.10 Nova Biomedical
13.10.1 Nova Biomedical Company Information
13.10.2 Nova Biomedical Point-of-Care Testing (POCT) Product Portfolios and Specifications
13.10.3 Nova Biomedical Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Nova Biomedical Main Business Overview
13.10.5 Nova Biomedical Latest Developments
13.11 Trividia Health
13.11.1 Trividia Health Company Information
13.11.2 Trividia Health Point-of-Care Testing (POCT) Product Portfolios and Specifications
13.11.3 Trividia Health Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Trividia Health Main Business Overview
13.11.5 Trividia Health Latest Developments
13.12 Quidel
13.12.1 Quidel Company Information
13.12.2 Quidel Point-of-Care Testing (POCT) Product Portfolios and Specifications
13.12.3 Quidel Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Quidel Main Business Overview
13.12.5 Quidel Latest Developments
13.13 Accriva
13.13.1 Accriva Company Information
13.13.2 Accriva Point-of-Care Testing (POCT) Product Portfolios and Specifications
13.13.3 Accriva Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Accriva Main Business Overview
13.13.5 Accriva Latest Developments
13.14 OraSure Technologies
13.14.1 OraSure Technologies Company Information
13.14.2 OraSure Technologies Point-of-Care Testing (POCT) Product Portfolios and Specifications
13.14.3 OraSure Technologies Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 OraSure Technologies Main Business Overview
13.14.5 OraSure Technologies Latest Developments
13.15 Helena Laboratories
13.15.1 Helena Laboratories Company Information
13.15.2 Helena Laboratories Point-of-Care Testing (POCT) Product Portfolios and Specifications
13.15.3 Helena Laboratories Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Helena Laboratories Main Business Overview
13.15.5 Helena Laboratories Latest Developments
13.16 A. Menarini Diagnostics
13.16.1 A. Menarini Diagnostics Company Information
13.16.2 A. Menarini Diagnostics Point-of-Care Testing (POCT) Product Portfolios and Specifications
13.16.3 A. Menarini Diagnostics Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 A. Menarini Diagnostics Main Business Overview
13.16.5 A. Menarini Diagnostics Latest Developments
13.17 Abaxis (Zoetis)
13.17.1 Abaxis (Zoetis) Company Information
13.17.2 Abaxis (Zoetis) Point-of-Care Testing (POCT) Product Portfolios and Specifications
13.17.3 Abaxis (Zoetis) Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Abaxis (Zoetis) Main Business Overview
13.17.5 Abaxis (Zoetis) Latest Developments
13.18 Ortho Clinical Diagnostics
13.18.1 Ortho Clinical Diagnostics Company Information
13.18.2 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Product Portfolios and Specifications
13.18.3 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Ortho Clinical Diagnostics Main Business Overview
13.18.5 Ortho Clinical Diagnostics Latest Developments
13.19 Phamatech
13.19.1 Phamatech Company Information
13.19.2 Phamatech Point-of-Care Testing (POCT) Product Portfolios and Specifications
13.19.3 Phamatech Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Phamatech Main Business Overview
13.19.5 Phamatech Latest Developments
13.20 Chembio Diagnostics
13.20.1 Chembio Diagnostics Company Information
13.20.2 Chembio Diagnostics Point-of-Care Testing (POCT) Product Portfolios and Specifications
13.20.3 Chembio Diagnostics Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Chembio Diagnostics Main Business Overview
13.20.5 Chembio Diagnostics Latest Developments
13.21 Trinity Biotech
13.21.1 Trinity Biotech Company Information
13.21.2 Trinity Biotech Point-of-Care Testing (POCT) Product Portfolios and Specifications
13.21.3 Trinity Biotech Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 Trinity Biotech Main Business Overview
13.21.5 Trinity Biotech Latest Developments
13.22 ELITech Group
13.22.1 ELITech Group Company Information
13.22.2 ELITech Group Point-of-Care Testing (POCT) Product Portfolios and Specifications
13.22.3 ELITech Group Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.22.4 ELITech Group Main Business Overview
13.22.5 ELITech Group Latest Developments
13.23 Response Biomedical
13.23.1 Response Biomedical Company Information
13.23.2 Response Biomedical Point-of-Care Testing (POCT) Product Portfolios and Specifications
13.23.3 Response Biomedical Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.23.4 Response Biomedical Main Business Overview
13.23.5 Response Biomedical Latest Developments
13.24 Princeton BioMeditech
13.24.1 Princeton BioMeditech Company Information
13.24.2 Princeton BioMeditech Point-of-Care Testing (POCT) Product Portfolios and Specifications
13.24.3 Princeton BioMeditech Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.24.4 Princeton BioMeditech Main Business Overview
13.24.5 Princeton BioMeditech Latest Developments
13.25 Alfa Wassermann
13.25.1 Alfa Wassermann Company Information
13.25.2 Alfa Wassermann Point-of-Care Testing (POCT) Product Portfolios and Specifications
13.25.3 Alfa Wassermann Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2023)
13.25.4 Alfa Wassermann Main Business Overview
13.25.5 Alfa Wassermann Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Point-of-Care Testing (POCT) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Point-of-Care Testing (POCT) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Blood Glucose Testing
Table 4. Major Players of Infectious Diseases Testing
Table 5. Major Players of Cardiac Markers Testing
Table 6. Major Players of Coagulation Testing
Table 7. Major Players of Pregnancy and Fertility Testing
Table 8. Major Players of Blood Gas/Electrolytes Testing
Table 9. Major Players of Urinalysis Testing
Table 10. Global Point-of-Care Testing (POCT) Sales by Type (2018-2023) & (M Units)
Table 11. Global Point-of-Care Testing (POCT) Sales Market Share by Type (2018-2023)
Table 12. Global Point-of-Care Testing (POCT) Revenue by Type (2018-2023) & ($ million)
Table 13. Global Point-of-Care Testing (POCT) Revenue Market Share by Type (2018-2023)
Table 14. Global Point-of-Care Testing (POCT) Sale Price by Type (2018-2023) & (USD/Unit)
Table 15. Global Point-of-Care Testing (POCT) Sales by Application (2018-2023) & (M Units)
Table 16. Global Point-of-Care Testing (POCT) Sales Market Share by Application (2018-2023)
Table 17. Global Point-of-Care Testing (POCT) Revenue by Application (2018-2023)
Table 18. Global Point-of-Care Testing (POCT) Revenue Market Share by Application (2018-2023)
Table 19. Global Point-of-Care Testing (POCT) Sale Price by Application (2018-2023) & (USD/Unit)
Table 20. Global Point-of-Care Testing (POCT) Sales by Company (2018-2023) & (M Units)
Table 21. Global Point-of-Care Testing (POCT) Sales Market Share by Company (2018-2023)
Table 22. Global Point-of-Care Testing (POCT) Revenue by Company (2018-2023) ($ Millions)
Table 23. Global Point-of-Care Testing (POCT) Revenue Market Share by Company (2018-2023)
Table 24. Global Point-of-Care Testing (POCT) Sale Price by Company (2018-2023) & (USD/Unit)
Table 25. Key Manufacturers Point-of-Care Testing (POCT) Producing Area Distribution and Sales Area
Table 26. Players Point-of-Care Testing (POCT) Products Offered
Table 27. Point-of-Care Testing (POCT) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Point-of-Care Testing (POCT) Sales by Geographic Region (2018-2023) & (M Units)
Table 31. Global Point-of-Care Testing (POCT) Sales Market Share Geographic Region (2018-2023)
Table 32. Global Point-of-Care Testing (POCT) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 33. Global Point-of-Care Testing (POCT) Revenue Market Share by Geographic Region (2018-2023)
Table 34. Global Point-of-Care Testing (POCT) Sales by Country/Region (2018-2023) & (M Units)
Table 35. Global Point-of-Care Testing (POCT) Sales Market Share by Country/Region (2018-2023)
Table 36. Global Point-of-Care Testing (POCT) Revenue by Country/Region (2018-2023) & ($ millions)
Table 37. Global Point-of-Care Testing (POCT) Revenue Market Share by Country/Region (2018-2023)
Table 38. Americas Point-of-Care Testing (POCT) Sales by Country (2018-2023) & (M Units)
Table 39. Americas Point-of-Care Testing (POCT) Sales Market Share by Country (2018-2023)
Table 40. Americas Point-of-Care Testing (POCT) Revenue by Country (2018-2023) & ($ Millions)
Table 41. Americas Point-of-Care Testing (POCT) Revenue Market Share by Country (2018-2023)
Table 42. Americas Point-of-Care Testing (POCT) Sales by Type (2018-2023) & (M Units)
Table 43. Americas Point-of-Care Testing (POCT) Sales by Application (2018-2023) & (M Units)
Table 44. APAC Point-of-Care Testing (POCT) Sales by Region (2018-2023) & (M Units)
Table 45. APAC Point-of-Care Testing (POCT) Sales Market Share by Region (2018-2023)
Table 46. APAC Point-of-Care Testing (POCT) Revenue by Region (2018-2023) & ($ Millions)
Table 47. APAC Point-of-Care Testing (POCT) Revenue Market Share by Region (2018-2023)
Table 48. APAC Point-of-Care Testing (POCT) Sales by Type (2018-2023) & (M Units)
Table 49. APAC Point-of-Care Testing (POCT) Sales by Application (2018-2023) & (M Units)
Table 50. Europe Point-of-Care Testing (POCT) Sales by Country (2018-2023) & (M Units)
Table 51. Europe Point-of-Care Testing (POCT) Sales Market Share by Country (2018-2023)
Table 52. Europe Point-of-Care Testing (POCT) Revenue by Country (2018-2023) & ($ Millions)
Table 53. Europe Point-of-Care Testing (POCT) Revenue Market Share by Country (2018-2023)
Table 54. Europe Point-of-Care Testing (POCT) Sales by Type (2018-2023) & (M Units)
Table 55. Europe Point-of-Care Testing (POCT) Sales by Application (2018-2023) & (M Units)
Table 56. Middle East & Africa Point-of-Care Testing (POCT) Sales by Country (2018-2023) & (M Units)
Table 57. Middle East & Africa Point-of-Care Testing (POCT) Sales Market Share by Country (2018-2023)
Table 58. Middle East & Africa Point-of-Care Testing (POCT) Revenue by Country (2018-2023) & ($ Millions)
Table 59. Middle East & Africa Point-of-Care Testing (POCT) Revenue Market Share by Country (2018-2023)
Table 60. Middle East & Africa Point-of-Care Testing (POCT) Sales by Type (2018-2023) & (M Units)
Table 61. Middle East & Africa Point-of-Care Testing (POCT) Sales by Application (2018-2023) & (M Units)
Table 62. Key Market Drivers & Growth Opportunities of Point-of-Care Testing (POCT)
Table 63. Key Market Challenges & Risks of Point-of-Care Testing (POCT)
Table 64. Key Industry Trends of Point-of-Care Testing (POCT)
Table 65. Point-of-Care Testing (POCT) Raw Material
Table 66. Key Suppliers of Raw Materials
Table 67. Point-of-Care Testing (POCT) Distributors List
Table 68. Point-of-Care Testing (POCT) Customer List
Table 69. Global Point-of-Care Testing (POCT) Sales Forecast by Region (2024-2029) & (M Units)
Table 70. Global Point-of-Care Testing (POCT) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Americas Point-of-Care Testing (POCT) Sales Forecast by Country (2024-2029) & (M Units)
Table 72. Americas Point-of-Care Testing (POCT) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. APAC Point-of-Care Testing (POCT) Sales Forecast by Region (2024-2029) & (M Units)
Table 74. APAC Point-of-Care Testing (POCT) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 75. Europe Point-of-Care Testing (POCT) Sales Forecast by Country (2024-2029) & (M Units)
Table 76. Europe Point-of-Care Testing (POCT) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Middle East & Africa Point-of-Care Testing (POCT) Sales Forecast by Country (2024-2029) & (M Units)
Table 78. Middle East & Africa Point-of-Care Testing (POCT) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 79. Global Point-of-Care Testing (POCT) Sales Forecast by Type (2024-2029) & (M Units)
Table 80. Global Point-of-Care Testing (POCT) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 81. Global Point-of-Care Testing (POCT) Sales Forecast by Application (2024-2029) & (M Units)
Table 82. Global Point-of-Care Testing (POCT) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 83. Roche Basic Information, Point-of-Care Testing (POCT) Manufacturing Base, Sales Area and Its Competitors
Table 84. Roche Point-of-Care Testing (POCT) Product Portfolios and Specifications
Table 85. Roche Point-of-Care Testing (POCT) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 86. Roche Main Business
Table 87. Roche Latest Developments
Table 88. Abbott Basic Information, Point-of-Care Testing (POCT) Manufacturing Base, Sales Area and Its Competitors
Table 89. Abbott Point-of-Care Testing (POCT) Product Portfolios and Specifications
Table 90. Abbott Point-of-Care Testing (POCT) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 91. Abbott Main Business
Table 92. Abbott Latest Developments
Table 93. Johnson & Johnson Basic Information, Point-of-Care Testing (POCT) Manufacturing Base, Sales Area and Its Competitors
Table 94. Johnson & Johnson Point-of-Care Testing (POCT) Product Portfolios and Specifications
Table 95. Johnson & Johnson Point-of-Care Testing (POCT) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 96. Johnson & Johnson Main Business
Table 97. Johnson & Johnson Latest Developments
Table 98. Siemens Healthcare Basic Information, Point-of-Care Testing (POCT) Manufacturing Base, Sales Area and Its Competitors
Table 99. Siemens Healthcare Point-of-Care Testing (POCT) Product Portfolios and Specifications
Table 100. Siemens Healthcare Point-of-Care Testing (POCT) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 101. Siemens Healthcare Main Business
Table 102. Siemens Healthcare Latest Developments
Table 103. Danaher Basic Information, Point-of-Care Testing (POCT) Manufacturing Base, Sales Area and Its Competitors
Table 104. Danaher Point-of-Care Testing (POCT) Product Portfolios and Specifications
Table 105. Danaher Point-of-Care Testing (POCT) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 106. Danaher Main Business
Table 107. Danaher Latest Developments
Table 108. Ascensia Basic Information, Point-of-Care Testing (POCT) Manufacturing Base, Sales Area and Its Competitors
Table 109. Ascensia Point-of-Care Testing (POCT) Product Portfolios and Specifications
Table 110. Ascensia Point-of-Care Testing (POCT) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 111. Ascensia Main Business
Table 112. Ascensia Latest Developments
Table 113. Bio-Rad Laboratories Basic Information, Point-of-Care Testing (POCT) Manufacturing Base, Sales Area and Its Competitors
Table 114. Bio-Rad Laboratories Point-of-Care Testing (POCT) Product Portfolios and Specifications
Table 115. Bio-Rad Laboratories Point-of-Care Testing (POCT) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 116. Bio-Rad Laboratories Main Business
Table 117. Bio-Rad Laboratories Latest Developments
Table 118. BioMerieux Basic Information, Point-of-Care Testing (POCT) Manufacturing Base, Sales Area and Its Competitors
Table 119. BioMerieux Point-of-Care Testing (POCT) Product Portfolios and Specifications
Table 120. BioMerieux Point-of-Care Testing (POCT) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 121. BioMerieux Main Business
Table 122. BioMerieux Latest Developments
Table 123. ARKRAY Basic Information, Point-of-Care Testing (POCT) Manufacturing Base, Sales Area and Its Competitors
Table 124. ARKRAY Point-of-Care Testing (POCT) Product Portfolios and Specifications
Table 125. ARKRAY Point-of-Care Testing (POCT) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 126. ARKRAY Main Business
Table 127. ARKRAY Latest Developments
Table 128. Nova Biomedical Basic Information, Point-of-Care Testing (POCT) Manufacturing Base, Sales Area and Its Competitors
Table 129. Nova Biomedical Point-of-Care Testing (POCT) Product Portfolios and Specifications
Table 130. Nova Biomedical Point-of-Care Testing (POCT) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 131. Nova Biomedical Main Business
Table 132. Nova Biomedical Latest Developments
Table 133. Trividia Health Basic Information, Point-of-Care Testing (POCT) Manufacturing Base, Sales Area and Its Competitors
Table 134. Trividia Health Point-of-Care Testing (POCT) Product Portfolios and Specifications
Table 135. Trividia Health Point-of-Care Testing (POCT) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 136. Trividia Health Main Business
Table 137. Trividia Health Latest Developments
Table 138. Quidel Basic Information, Point-of-Care Testing (POCT) Manufacturing Base, Sales Area and Its Competitors
Table 139. Quidel Point-of-Care Testing (POCT) Product Portfolios and Specifications
Table 140. Quidel Point-of-Care Testing (POCT) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 141. Quidel Main Business
Table 142. Quidel Latest Developments
Table 143. Accriva Basic Information, Point-of-Care Testing (POCT) Manufacturing Base, Sales Area and Its Competitors
Table 144. Accriva Point-of-Care Testing (POCT) Product Portfolios and Specifications
Table 145. Accriva Point-of-Care Testing (POCT) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 146. Accriva Main Business
Table 147. Accriva Latest Developments
Table 148. OraSure Technologies Basic Information, Point-of-Care Testing (POCT) Manufacturing Base, Sales Area and Its Competitors
Table 149. OraSure Technologies Point-of-Care Testing (POCT) Product Portfolios and Specifications
Table 150. OraSure Technologies Point-of-Care Testing (POCT) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 151. OraSure Technologies Main Business
Table 152. OraSure Technologies Latest Developments
Table 153. Helena Laboratories Basic Information, Point-of-Care Testing (POCT) Manufacturing Base, Sales Area and Its Competitors
Table 154. Helena Laboratories Point-of-Care Testing (POCT) Product Portfolios and Specifications
Table 155. Helena Laboratories Point-of-Care Testing (POCT) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 156. Helena Laboratories Main Business
Table 157. Helena Laboratories Latest Developments
Table 158. A. Menarini Diagnostics Basic Information, Point-of-Care Testing (POCT) Manufacturing Base, Sales Area and Its Competitors
Table 159. A. Menarini Diagnostics Point-of-Care Testing (POCT) Product Portfolios and Specifications
Table 160. A. Menarini Diagnostics Point-of-Care Testing (POCT) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 161. A. Menarini Diagnostics Main Business
Table 162. A. Menarini Diagnostics Latest Developments
Table 163. Abaxis (Zoetis) Basic Information, Point-of-Care Testing (POCT) Manufacturing Base, Sales Area and Its Competitors
Table 164. Abaxis (Zoetis) Point-of-Care Testing (POCT) Product Portfolios and Specifications
Table 165. Abaxis (Zoetis) Point-of-Care Testing (POCT) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 166. Abaxis (Zoetis) Main Business
Table 167. Abaxis (Zoetis) Latest Developments
Table 168. Ortho Clinical Diagnostics Basic Information, Point-of-Care Testing (POCT) Manufacturing Base, Sales Area and Its Competitors
Table 169. Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Product Portfolios and Specifications
Table 170. Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 171. Ortho Clinical Diag
Global Influenza Diagnostics Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 85
Influenza is an infectious disease and affects The upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to The influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are The essential first step for laboratory detection of influenz......
Global Tuberculosis (TB) Diagnostics Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 107
According to our LPI (LP Information) latest study, the global Tuberculosis (TB) Diagnostics market size was valued at US$ 2572.8 million in 2023. With growing demand in downstream market, the Tuberculosis (TB) Diagnostics is forecast to a readjusted size of US$ 3540.9 million by 2030 with a CAGR of 4.7% during review period.
The research report highlights the growth potential of the global Tuberculosis (TB) Diagnostics market. Tuberculosis (TB) Diagnostics are expected to show stable gr......
Global POC Diagnostics Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 128
According to our LPI (LP Information) latest study, the global POC Diagnostics market size was valued at US$ 25110 million in 2023. With growing demand in downstream market, the POC Diagnostics is forecast to a readjusted size of US$ 48170 million by 2030 with a CAGR of 9.8% during review period.
The research report highlights the growth potential of the global POC Diagnostics market. POC Diagnostics are expected to show stable growth in the future market. However, product differentiatio......
Global Allergy Diagnostics Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 109
According to our LPI (LP Information) latest study, the global Allergy Diagnostics market size was valued at US$ 5070.7 million in 2023. With growing demand in downstream market, the Allergy Diagnostics is forecast to a readjusted size of US$ 10550 million by 2030 with a CAGR of 11.0% during review period.
The research report highlights the growth potential of the global Allergy Diagnostics market. Allergy Diagnostics are expected to show stable growth in the future market. However, prod......
Global Influenza Diagnostics Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 100
According to our LPI (LP Information) latest study, the global Influenza Diagnostics market size was valued at US$ 2284.7 million in 2023. With growing demand in downstream market, the Influenza Diagnostics is forecast to a readjusted size of US$ 3558.7 million by 2030 with a CAGR of 6.5% during review period.
The research report highlights the growth potential of the global Influenza Diagnostics market. Influenza Diagnostics are expected to show stable growth in the future market. Howev......
Global Tuberculosis (TB) Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 112
According to our (Global Info Research) latest study, the global Tuberculosis (TB) Diagnostics market size was valued at USD 2706.1 million in 2023 and is forecast to a readjusted size of USD 3635.2 million by 2030 with a CAGR of 4.3% during review period.
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, i......
Global Influenza Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 111
According to our (Global Info Research) latest study, the global Influenza Diagnostics market size was valued at USD 2403.1 million in 2023 and is forecast to a readjusted size of USD 3620.3 million by 2030 with a CAGR of 6.0% during review period.
Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus......
Global Point-of-Care Diagnostics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 12-Dec-2023 Price: US 3380 Onwards Pages: 122
Market Overview of Global Point-of-Care Diagnostics market:
According to our latest research, the global Point-of-Care Diagnostics market looks promising in the next 5 years. As of 2022, the global Point-of-Care Diagnostics market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the glo......
Global Viral Disease Diagnosis Professional Survey Report 2023, Forecast to 2028
Published: 27-Nov-2023 Price: US 3280 Onwards Pages: 105
They have been used as an alternative method of diagnosing viral diseases.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared acr......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
